Agenus | AGEN - 流动资产



金融业
股票价格
USD
资产
USD 172.69M
现金及等价物
USD 18.74M
销售成本
USD 642K
流动资产
USD 78.81M
流动负债
USD 231.82M
债务
USD 35.54M
股息收益率
0
EBIT
USD 15.05M
EBITDA
USD -10.11M
员工
389
EPS每股收益
USD 1.02
股本和储备
USD -199.08M
销售毛利
USD 33.74M
债务利息支出
USD 14.67M
贷款资金
USD 153.99M
市值
USD 2.95B
净收入
USD 39.17M
营业费用
USD -199.08M
营业利润
USD 15.05M
普通股股本
USD 38.52M
PE价格收益
17.82
税前利润
USD 39.21M
销售收入
USD 33.7M
销售和管理费用
USD 6.21M
贸易债权人
USD 58.98M
应收帐款人
USD 22.34M


流动资产 更改 日
AbbVie USD 33.67B 140M 2026-06
Agenus USD 78.81M 16.47M 2026-06
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Celldex Therapeutics USD 724.93M 265.71M 2026-06
CSL USD 11.85B 1000K 2025-12
Eli Lilly USD 64.67B 9.84B 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Glaxosmithkline GBP 17.76B 5.83B 2026-03
Incyte USD 6.03B 542.31M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
J&J USD 59.77B 601M 2026-06
Jiangsu Hengrui CNY 52.04B 553.82M 2026-03
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Merck EUR 13.77B 393M 2026-06
Merck USD 36.68B 1.66B 2026-06
Northwest Biotherapeutics USD 6.2M 996K 2026-03
Novartis USD 27.35B 744M 2026-06
Novavax USD 771.1M 79.72M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 574.78M 52.6M 2026-06